Has Amy Huber, MD received payments from drug or device companies?

Yes. Drug and device makers reported $4,824 in general payments to Amy Huber, MD across 260 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Amy Huber, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Amy Huber, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Amy Huber, MD

MOHS-Micrographic Surgery · Memphis, TNNPI 1215904602

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 17.7% — the pattern of someone who eats at a lot of different presentations.

$4,824in general payments, 2019–2025

Across 260 payments — averaging $18.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$856
Novartis$850
Johnson & Johnson$799
Sanofi$498
Sun Pharmaceutical Industries Inc.$404
Regeneron Healthcare Solutions, Inc.$344
plus $1K from 15 others

What the payments were for

Food & beverage$4,68097%
Education$1443%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	67	$856
Novartis	51	$850
Johnson & Johnson	38	$799
Sanofi	21	$498
Sun Pharmaceutical Industries Inc.	20	$404
Regeneron Healthcare Solutions, Inc.	14	$344
Genentech USA, Inc.	7	$227
Incyte Corporation	4	$133
Arcutis Biotherapeutics, Inc.	7	$123
Lilly USA, LLC	6	$107
E.r. Squibb & Sons, L.L.C.	4	$89
Galderma Laboratories, L.p.	5	$70
Pfizer	4	$68
UCB, Inc.	3	$57
Misonix Inc	2	$51
LEO Pharma Inc.	2	$39
Mayne Pharma Commercial LLC	1	$26
Organogenesis Inc.	1	$23
Botanix SB Inc	1	$23
Ortho Dermatologics, A Division Of Bausch Health US, LLC	1	$22
Blueprint Medicines Corporation	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Erivedge$125

How this compares

$4,824 in reported general payments places this provider in the 55th percentile of 40 mohs-micrographic surgery providers in Tennessee.

See all mohs-micrographic surgery providers in Tennessee →

Medicare billing

Part B allowed, 2024

$844,898

Medicare patients

1,117

Services billed

6,752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	151	$1,762
Clobetasol Propionate	27	$804
Triamcinolone Acetonide	59	$803
Metronidazole	17	$557
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	109	$506
Nystatin	14	$181
Mupirocin	16	$164
ValacyclovirValacyclovir Hcl	11	$146
Zolpidem Tartrate	11	$79

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Memphis

Courtney WoodmanseeMemphis$9K
Brent MoodyNashville$1M
Vineet MishraNashville$44K
Margaret MannHendersonville$16K
Dafnis CarranzaHumboldt$13K
Joseph ProhaskaMorristown$11K
Megan MorrisonThompsons Station$10K
Michael PelsterNashville$10K
Matthew HanggiKnoxville$9K
Vlatka AgnettaChattanooga$9K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →